Pulse Biosciences (PLSE) Current Deferred Revenue (2017 - 2023)

Pulse Biosciences' (PLSE) quarterly Current Deferred Revenue came in at $4000.0 in Q1 2023, down 75.0% year-on-year from $16000.0 in Q1 2022, and down 89.47% quarter-over-quarter from $38000.0 in Q3 2022.

Pulse Biosciences (PLSE) Current Deferred Revenue (2017 - 2023) Analysis & Trends

Pulse Biosciences' Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $4000.0 for Q1 2023.

  • On a quarterly basis, Current Deferred Revenue fell 75.0% year-over-year to $4000.0 in Q1 2023; TTM through Mar 2023 was $4000.0, a 75.0% decrease from a year earlier, with the FY2021 full-year figure at $16000.0, changed N/A from the prior year.
  • Current Deferred Revenue eased to $4000.0 in Q1 2023 per PLSE's latest filing, from $38000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $38000.0 in Q3 2022 and bottomed at $4000.0 in Q1 2023.
  • The 3-year median for Current Deferred Revenue is $16000.0 (2021), against an average of $18833.3.
  • Across the five-year window, Current Deferred Revenue soared 442.86% in 2022 and sank 75.0% in 2023, its largest moves.
  • Year by year, Current Deferred Revenue stood at $16000.0 in 2021, then surged by 137.5% to $38000.0 in 2022, then slumped by 89.47% to $4000.0 in 2023.
  • Per Business Quant, the three latest PLSE Current Deferred Revenue figures stand at $4000.0 (Q1 2023), $38000.0 (Q3 2022), and $32000.0 (Q2 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Pulse Biosciences 2.09 Bn 2.01 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2023 4,000.00
Sep 30, 2022 38,000.00
Jun 30, 2022 32,000.00
Mar 31, 2022 16,000.00
Dec 31, 2021 16,000.00
Sep 30, 2021 7,000.00
Dec 31, 2018 415,000.00
Sep 30, 2018 410,000.00
Jun 30, 2018 406,000.00
Mar 31, 2018 401,000.00
Dec 31, 2017 397,000.00
Sep 30, 2017 392,000.00
Jun 30, 2017 303,000.00